Skip to main content

Advertisement

SpringerLink
Log in

Endobronchial Ultrasound (EBUS) for Staging Lung Cancer in the Elderly Population—Specific Procedural and Medication Issues

  • Pulmonology and Respiratory Care (D Breen, Section Editor)
  • Published:
Current Geriatrics Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Lung cancer is the leading cause of cancer mortality, and in the ageing population, the elderly account for the majority of cases. Treatment options are continually expanding, and when patients of a good performance status are suspected of having lung cancer, a systematic assessment to confirm the diagnosis and establish a stage is necessary. Endobronchial ultrasound (EBUS) is a key tool, and we explore the utility of this in the elderly population.

Recent Findings

Over the past 20 years, EBUS has been shown to be an invaluable tool, comparable and exceeding in some cases the traditional mediastinoscopy. Studies show that EBUS can be performed with low complication rates and under moderate sedation, while in the elderly population, data demonstrates that it is safe and effective.

Summary

The elderly population shares the highest burden of thoracic malignancy, and building evidence suggests that EBUS is an effective diagnostic and staging tool, which can be safely performed in this patient group.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig 1.

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. https://doi.org/10.3322/caac.21262.

    Article  PubMed  Google Scholar 

  2. •• Royal College of Physicians CQID, January 2018. National Lung Cancer Audit annual report 2017 (for the audit period 2016) Royal College of Physicians, Care Quality Improvement Department. 2018. This annual national UK audit gives the most accurate representation of newly diagnosed lung cancers in a population.

  3. Tas F, Ciftci R, Kilic L, Karabulut S. Age is a prognostic factor affecting survival in lung cancer patients. Oncol Lett. 2013;6(5):1507–13. https://doi.org/10.3892/ol.2013.1566.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. West HJ, Jin JOJAMA. Oncology patient page. Performance status in patients with cancer. JAMA Oncol. 2015;1(7):998. https://doi.org/10.1001/jamaoncol.2015.3113.

    Article  PubMed  Google Scholar 

  5. Statistics OoN. Cancer registration statistics England. Office of National statistics UK 2016.

  6. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, et al. SEER cancer statistics review (CSR) 1975-2012: lung and bronchus. Natl Cancer Inst. 2014;

  7. •• Asamura H, Chansky K, Crowley J, Goldstraw P, Rusch VW, Vansteenkiste JF, et al. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming 8th edition of the TNM classification for lung cancer. J Thorac Oncol. 2015;10(12):1675–84. https://doi.org/10.1097/JTO.0000000000000678. Updated information on the TNM 8 th edition staging information for nodal disease.

    Article  PubMed  CAS  Google Scholar 

  8. •• Silvestri GA, Gonzalez AV, Jantz MA, Margolis ML, Gould MK, Tanoue LT, Harris LJ, Detterbeck FC Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013;143(5 Suppl):e211S-e50S. doi:https://doi.org/10.1378/chest.12-2355. These American guidelines for staging non-small cell lung cancer are detailed, reviewing the evidence and making varying levels of recommendations based on systematic reviews, e250S.

  9. De leyn P, Dooms C, Kuzdzal J, Lardinois D, Passlick B, Rami-Porta R, et al. Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer. Eur J Cardiothorac Surg. 2014;45(5):787–98. https://doi.org/10.1093/ejcts/ezu028.

    Article  PubMed  Google Scholar 

  10. NICE. Lung cancer: diagnosis and management. National Institute for Health and Care Excellence. 2011.

  11. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–55.

    Article  PubMed  CAS  Google Scholar 

  12. Yates JW, Chalmer B, McKegney FP. Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer. 1980;45(8):2220–4.

    Article  PubMed  CAS  Google Scholar 

  13. Buccheri G, Ferrigno D, Tamburini M. Karnofsky and ECOG performance status scoring in lung cancer: a prospective, longitudinal study of 536 patients from a single institution. Eur J Cancer. 1996;32A(7):1135–41.

    Article  PubMed  CAS  Google Scholar 

  14. Gridelli C, Ardizzoni A, Le Chevalier T, Manegold C, Perrone F, Thatcher N, et al. Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel. Ann Oncol. 2004;15(3):419–26.

    Article  PubMed  CAS  Google Scholar 

  15. Aggarwal C, Langer CJ. Older age, poor performance status and major comorbidities: how to treat high-risk patients with advanced nonsmall cell lung cancer. Curr Opin Oncol. 2012;24(2):130–6. https://doi.org/10.1097/CCO.0b013e32834ea6ea.

    Article  PubMed  Google Scholar 

  16. de Rijke JM, Schouten LJ, ten Velde GP, Wanders SL, Bollen EC, Lalisang RI, et al. Influence of age, comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer; results of a population-based study. Lung Cancer. 2004;46(2):233–45. https://doi.org/10.1016/j.lungcan.2004.03.011.

    Article  PubMed  Google Scholar 

  17. Driessen EJM, Schulkes KJG, Dingemans AC, van Loon JGM, Hamaker ME, Aarts MJ, et al. Patterns of treatment and survival among older patients with stage III non-small cell lung cancer. Lung Cancer. 2018;116:55–61. https://doi.org/10.1016/j.lungcan.2017.12.013.

    Article  PubMed  Google Scholar 

  18. Hino H, Karasaki T, Yoshida Y, Fukami T, Sano A, Tanaka M, et al. Risk factors for postoperative complications and long-term survival in lung cancer patients older than 80 years. Eur J Cardiothorac Surg. 2017;53:980–6. https://doi.org/10.1093/ejcts/ezx437.

    Article  Google Scholar 

  19. Okami J, Higashiyama M, Asamura H, Goya T, Koshiishi Y, Sohara Y, et al. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications. J Thorac Oncol. 2009;4(10):1247–53. https://doi.org/10.1097/JTO.0b013e3181ae285d.

    Article  PubMed  Google Scholar 

  20. Furuta M, Hayakawa K, Katano S, Saito Y, Nakayama Y, Takahashi T, et al. Radiation therapy for stage I-II non-small cell lung cancer in patients aged 75 years and older. Jpn J Clin Oncol. 1996;26(2):95–8.

    Article  PubMed  CAS  Google Scholar 

  21. • Samuels MA, Kandula S, Koru-Sengul T, Bogart JA, Salama JK, Aridgides PD, et al. Stereotactic body radiotherapy in patients with stage I non-small-cell lung cancer aged 75 years and older: retrospective results from a multicenter consortium. Clin Lung Cancer. 2013;14(4):446–51. https://doi.org/10.1016/j.cllc.2013.03.004. A retrospective study in the elderly population undergoing stereotactic radiotherapy, demonstrating excellent tolerance and response rates.

    Article  PubMed  Google Scholar 

  22. Stokes WA, Bronsert MR, Meguid RA, Blum MG, Jones BL, Koshy M, et al. Post-treatment mortality after surgery and stereotactic body radiotherapy for early-stage non-small-cell lung cancer. J Clin Oncol. 2018;36(7):642–51. https://doi.org/10.1200/JCO.2017.75.6536.

    Article  PubMed  Google Scholar 

  23. Schrevens L, Lorent N, Dooms C, Vansteenkiste J. The role of PET scan in diagnosis, staging, and management of non-small cell lung cancer. Oncologist. 2004;9(6):633–43. https://doi.org/10.1634/theoncologist.9-6-633.

    Article  PubMed  Google Scholar 

  24. Fischer B, Lassen U, Mortensen J, Larsen S, Loft A, Bertelsen A, et al. Preoperative staging of lung cancer with combined PET-CT. N Engl J Med. 2009;361(1):32–9. https://doi.org/10.1056/NEJMoa0900043.

    Article  PubMed  CAS  Google Scholar 

  25. Fielding DI, Kurimoto N. EBUS-TBNA/staging of lung cancer. Clin Chest Med. 2013;34(3):385–94. https://doi.org/10.1016/j.ccm.2013.06.003.

    Article  PubMed  Google Scholar 

  26. Rintoul RC, Tournoy KG, El Daly H, Carroll NR, Buttery RC, van Kralingen K, et al. EBUS-TBNA for the clarification of PET positive intra-thoracic lymph nodes—an international multi-centre experience. J Thorac Oncol : Off Publ Int Assoce Stud Lung Cancer. 2009;4(1):44–8. https://doi.org/10.1097/JTO.0b013e3181914357.

    Article  Google Scholar 

  27. Herth FJF, Eberhardt R, Krasnik M, Ernst A. Endobronchial ultrasound-guided transbronchial needle aspiration of lymph nodes in the radiologically and positron emission tomography-normal mediastinum in patients with lung cancer. Chest. 2008;133(4):887–91. https://doi.org/10.1378/chest.07-2535.

    Article  PubMed  Google Scholar 

  28. Vilmann P, Clementsen PF, Colella S, Siemsen M, De Leyn P, Dumonceau JM, et al. Combined endobronchial and oesophageal endosonography for the diagnosis and staging of lung cancer. European Society of Gastrointestinal Endoscopy (ESGE) Guideline, in cooperation with the European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS). Eur Respir J. 2015;46(1):40–60. https://doi.org/10.1183/09031936.00064515.

    Article  PubMed  Google Scholar 

  29. Cameron RB, Andaz S, Hoal G, Hua-Feng L, Doyle M, Benfield J. Extended cervical mediastinoscopy (ECM) for biopsy of aortopulmonary window (APW) lymph nodes and an APW index (APWI) useful in patient selection. J Thorac Oncol. 2015;10(9 SUPPL. 2):S336.

    Google Scholar 

  30. AC K, FC D. General aspects of surgical treatment. diagnosis and treatment of lung cancer: an evidence- based guide for the practicing clinician. Philadelphia: WB Saunders; 2001.

    Google Scholar 

  31. Zakkar M, Tan C, Hunt I. Is video mediastinoscopy a safer and more effective procedure than conventional mediastinoscopy? Interact Cardiovasc Thorac Surg. 2012;14(1):81–4. https://doi.org/10.1093/icvts/ivr044.

    Article  PubMed  Google Scholar 

  32. Sampsonas F, Kakoullis L, Lykouras D, Karkoulias K, Spiropoulos K. EBUS: faster, cheaper and most effective in lung cancer staging. Int J Clin Pract. 2018;72 https://doi.org/10.1111/ijcp.13053.

  33. •• Navani N, Nankivell M, Lawrence DR, Lock S, Makker H, Baldwin DR, et al. Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic randomised controlled trial. Lancet Respir Med. 2015;3(4):282–9. https://doi.org/10.1016/S2213-2600(15)00029-6. This study randomised patients to undergo conventional versus EBUS staging, and demonstrated the power of EBUS in improving the time to diagnosis and decision-making in patients with lung cancer.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Erer OF, Erol S, Anar C, Aydogdu Z, Ozkan SA. Diagnostic yield of EBUS-TBNA for lymphoma and review of the literature. Endosc Ultrasound. 2017;6(5):317–22. https://doi.org/10.4103/2303-9027.180762.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Lin SM, Ni YL, Kuo CH, Lin TY, Wang TY, Chung FT, et al. Endobronchial ultrasound increases the diagnostic yields of polymerase chain reaction and smear for pulmonary tuberculosis. J Thorac Cardiovasc Surg. 2010;139(6):1554–60. https://doi.org/10.1016/j.jtcvs.2010.02.019.

    Article  PubMed  Google Scholar 

  36. Gupta D, Dadhwal DS, Agarwal R, Gupta N, Bal A, Aggarwal AN. Endobronchial ultrasound-guided transbronchial needle aspiration vs conventional transbronchial needle aspiration in the diagnosis of sarcoidosis. Chest. 2014;146(3):547–56. https://doi.org/10.1378/chest.13-2339.

    Article  PubMed  Google Scholar 

  37. Verma A, Jeon K, Koh WJ, Suh GY, Chung MP, Kim H, et al. Endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis of central lung parenchymal lesions. Yonsei Med J. 2013;54(3):672–8. https://doi.org/10.3349/ymj.2013.54.3.672.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Nakajima T, Yasufuku K, Shibuya K, Fujisawa T. Endobronchial ultrasound-guided transbronchial needle aspiration for the treatment of central airway stenosis caused by a mediastinal cyst. Eur J Cardiothorac Surg. 2007;32(3):538–40. https://doi.org/10.1016/j.ejcts.2007.06.010.

    Article  PubMed  Google Scholar 

  39. Safety WAfP. Implementation manual WHO surgical safety check list (first edition). In: Organization WH, editor. First ed. United States of America: WHO publications; 2008.

  40. Domain NEpS. National safety standards for invasive procedures. NHS England. 2015.

  41. Weld LR, Stringer MT, Ebertowski JS, Baumgartner TS, Kasprenski MC, Kelley JC, et al. TeamSTEPPS improves operating room efficiency and patient safety. Am J Med Qual. 2016;31(5):408–14. https://doi.org/10.1177/1062860615583671.

    Article  PubMed  Google Scholar 

  42. NHS England (2015) Never events list 2015/16. NHS England 2015.

  43. Du Rand IA, Barber PV, Goldring J, Lewis RA, Mandal S, Munavvar M, et al. Summary of the British Thoracic Society guidelines for advanced diagnostic and therapeutic flexible bronchoscopy in adults. Thorax. 2011;66(11):1014–5. https://doi.org/10.1136/thoraxjnl-2011-201052.

    Article  PubMed  Google Scholar 

  44. • Wahidi MM, Herth F, Yasufuku K, Shepherd RW, Yarmus L, Chawla M, et al. Technical aspects of endobronchial ultrasound-guided transbronchial needle aspiration: CHEST guideline and expert panel report. Chest. 2016;149(3):816–35. https://doi.org/10.1378/chest.15-1216. This series of systematic reviews examines various technical aspects of performing EBUS.

    Article  PubMed  Google Scholar 

  45. Kristjansson SR, Nesbakken A, Jordhoy MS, Skovlund E, Audisio RA, Johannessen HO, et al. Comprehensive geriatric assessment can predict complications in elderly patients after elective surgery for colorectal cancer: a prospective observational cohort study. Crit Rev Oncol Hematol. 2010;76(3):208–17. https://doi.org/10.1016/j.critrevonc.2009.11.002.

    Article  PubMed  Google Scholar 

  46. Yarmus LB, Akulian JA, Gilbert C, Mathai SC, Sathiyamoorthy S, Sahetya S, et al. Comparison of moderate versus deep sedation for endobronchial ultrasound transbronchial needle aspiration. Ann Amer Thorac Soc. 2013;10(2):121–6. https://doi.org/10.1513/AnnalsATS.201209-074OC.

    Article  Google Scholar 

  47. Casal RF, Lazarus DR, Kuhl K, Nogueras-Gonzalez G, Perusich S, Green LK, et al. Randomized trial of endobronchial ultrasound-guided transbronchial needle aspiration under general anesthesia versus moderate sedation. Am J Respir Crit Care Med. 2015;191(7):796–803. https://doi.org/10.1164/rccm.201409-1615OC.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Franzen D, Schneiter D, Weder W, Kohler M. Impact of sedation technique on the diagnostic accuracy of endobronchial ultrasound-guided transbronchial needle aspiration. Endosc Ultrasound. 2017;6(4):257–63. https://doi.org/10.4103/2303-9027.190925.

    Article  PubMed  PubMed Central  Google Scholar 

  49. • Ost DE, Ernst A, Lei X, Feller-Kopman D, Eapen GA, Kovitz KL, et al. Diagnostic yield of endobronchial ultrasound-guided transbronchial needle aspiration: results of the AQuIRE Bronchoscopy Registry. Chest. 2011;140(6):1557–66. https://doi.org/10.1378/chest.10-2914. This is a large, predominantly U.S. registry of interventional pulmonology—with useful information on EBUS results and complications.

  50. Antoniades N, Worsnop C. Topical lidocaine through the bronchoscope reduces cough rate during bronchoscopy. Respirology. 2009;14(6):873–6. https://doi.org/10.1111/j.1440-1843.2009.01587.x.

    Article  PubMed  Google Scholar 

  51. Kaur H, Dhooria S, Aggarwal AN, Gupta D, Behera D, Agarwal R. A randomized trial of 1% vs 2% lignocaine by the spray-as-you-go technique for topical anesthesia during flexible bronchoscopy. Chest. 2015;148(3):739–45. https://doi.org/10.1378/chest.15-0022.

    Article  PubMed  Google Scholar 

  52. Webb J. Local anaesthesia for fibreoptic bronchoscopy—where are we now? Respir Med. 1990;84(5):349–50.

    Article  PubMed  CAS  Google Scholar 

  53. Ameer B, Burlingame MB, Harman EM. Systemic absorption of topical lidocaine in elderly and young adults undergoing bronchoscopy. Pharmacotherapy. 1989;9(2):74–81.

    Article  PubMed  CAS  Google Scholar 

  54. Du Rand IA, Blaikley J, Booton R, Chaudhuri N, Gupta V, Khalid S, et al. British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE. Thorax. 2013;68(Suppl 1):i1–i44. https://doi.org/10.1136/thoraxjnl-2013-203618.

    Article  PubMed  Google Scholar 

  55. Cox B, Durieux ME, Marcus MA. Toxicity of local anaesthetics. Best Pract Res Clin Anaesthesiol. 2003;17(1):111–36.

    Article  PubMed  CAS  Google Scholar 

  56. Watts MR, Geraghty R, Moore A, Saunders J, Swift CG. Premedication for bronchoscopy in older patients: a double-blind comparison of two regimens. Respir Med. 2005;99(2):220–6.

    Article  PubMed  CAS  Google Scholar 

  57. (NCEPOD) NCEiPOaD. Elderly patients vulnerable because of excessive doses of sedatives. NCEPOD. 2004.

  58. Naidich DP, Harkin TJ. Airways and lung: correlation of CT with fiberoptic bronchoscopy. Radiology. 1995;197(1):1–12. https://doi.org/10.1148/radiology.197.1.7568805.

    Article  PubMed  CAS  Google Scholar 

  59. Lee HS, Lee GK, Lee HS, Kim MS, Lee JM, Kim HY, et al. Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station? Chest. 2008;134(2):368–74. https://doi.org/10.1378/chest.07-2105.

    Article  PubMed  Google Scholar 

  60. Yarmus L, Akulian J, Gilbert C, Feller-Kopman D, Lee HJ, Zarogoulidis P, et al. Optimizing endobronchial ultrasound for molecular analysis. How many passes are needed? Ann Am Thorac Soc. 2013;10(6):636–43. https://doi.org/10.1513/AnnalsATS.201305-130OC.

    Article  PubMed  Google Scholar 

  61. Wang Memoli JS, El-Bayoumi E, Pastis NJ, Tanner NT, Gomez M, Huggins JT, et al. Using endobronchial ultrasound features to predict lymph node metastasis in patients with lung cancer. Chest. 2011;140(6):1550–6. https://doi.org/10.1378/chest.11-0252.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Trisolini R, Cancellieri A, Tinelli C, de Biase D, Valentini I, Casadei G, et al. Randomized trial of endobronchial ultrasound-guided transbronchial needle aspiration with and without rapid on-site evaluation for lung cancer genotyping. Chest. 2015;148(6):1430–7. https://doi.org/10.1378/chest.15-0583.

    Article  PubMed  Google Scholar 

  63. Sehgal IS, Dhooria S, Aggarwal AN, Agarwal R. Impact of rapid on-site cytological evaluation (ROSE) on the diagnostic yield of transbronchial needle aspiration during mediastinal lymph node sampling: systematic review and meta-analysis. Chest. 2017;153:929–38. https://doi.org/10.1016/j.chest.2017.11.004.

    Article  PubMed  Google Scholar 

  64. Ofiara LM, Navasakulpong A, Beaudoin S, Gonzalez AV. Optimizing tissue sampling for the diagnosis, subtyping, and molecular analysis of lung cancer. Front Oncol. 2014;4:253. https://doi.org/10.3389/fonc.2014.00253.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Nguyen S, Ferland N, Beaudoin S, Martel S, Simon M, Laberge F, et al. Influence of trainee involvement on procedural characteristics for linear endobronchial ultrasound. Thorac Cancer. 2017;8(5):517–22. https://doi.org/10.1111/1759-7714.12481.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  66. Eapen GA, Shah AM, Lei X, Jimenez CA, Morice RC, Yarmus L, et al. Complications, consequences, and practice patterns of endobronchial ultrasound-guided transbronchial needle aspiration: results of the AQuIRE registry. Chest. 2013;143(4):1044–53. https://doi.org/10.1378/chest.12-0350.

    Article  PubMed  Google Scholar 

  67. Evison M, Crosbie PAJ, Martin J, Bishop P, Doran H, Joseph L, et al. EBUS-TBNA in elderly patients with lung cancer: safety and performance outcomes. J Thorac Oncol : Off Publ Int Assoc Stud Lung Cancer. 2014;9(3):370–6. https://doi.org/10.1097/JTO.0000000000000085.

    Article  Google Scholar 

  68. Kayawake H, Chen-Yoshikawa TF, Oda H, Motoyama H, Hamaji M, Menju T, et al. Complications of endobronchial ultrasound-guided transbronchial needle aspiration. Ann Thorac Surg. 2017;104(5):e363–e5. https://doi.org/10.1016/j.athoracsur.2017.06.015.

    Article  PubMed  Google Scholar 

  69. Kuchuk M, Guber A, Koslow M, Matveitchouk A, Shitrit D. Endoscopic ultrasound examination in elderly lung patients: our experience at meir medical center. Harefuah. 2015;154(8):481–542.

    PubMed  Google Scholar 

  70. Okachi S, Imai N, Imaizumi K, Hase T, Shindo Y, Sakamoto K, et al. Endobronchial ultrasound transbronchial needle aspiration in older people. Geriatr Gerontol Int. 2013;13(4):986–92. https://doi.org/10.1111/ggi.12043.

    Article  PubMed  Google Scholar 

  71. Holty JE, Kuschner WG, Gould MK. Accuracy of transbronchial needle aspiration for mediastinal staging of non-small cell lung cancer: a meta-analysis. Thorax. 2005;60(11):949–55. https://doi.org/10.1136/thx.2005.041525.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Jaffe TA, Raiff D, Ho LM, Kim CY. Management of anticoagulant and antiplatelet medications in adults undergoing percutaneous interventions. AJR Am J Roentgenol. 2015;205(2):421–8. https://doi.org/10.2214/AJR.14.13342.

    Article  PubMed  Google Scholar 

  73. Pathak V, Allender JE, Grant MW. Management of anticoagulant and antiplatelet therapy in patients undergoing interventional pulmonary procedures. Eur Respir Rev. 2017;26(145):170020. https://doi.org/10.1183/16000617.0020-2017.

    Article  PubMed  Google Scholar 

  74. Ernst A, Eberhardt R, Wahidi M, Becker HD, Herth FJ. Effect of routine clopidogrel use on bleeding complications after transbronchial biopsy in humans. Chest. 2006;129(3):734–7. https://doi.org/10.1378/chest.129.3.734.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Thoracic Medicine, Plymouth Hospitals NHS Trust, Plymouth, UK

    Lindsey Taylor, Kate Webster & Cyrus Daneshvar

Authors
  1. Lindsey Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kate Webster
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cyrus Daneshvar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cyrus Daneshvar.

Ethics declarations

Conflict of Interest

Lindsey Taylor, Kate Webster and Cyrus Daneshvar declare no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Pulmonology and Respiratory Care

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Taylor, L., Webster, K. & Daneshvar, C. Endobronchial Ultrasound (EBUS) for Staging Lung Cancer in the Elderly Population—Specific Procedural and Medication Issues. Curr Geri Rep 7, 190–199 (2018). https://doi.org/10.1007/s13670-018-0251-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13670-018-0251-3

Keywords

Search

Navigation